Ionis Pharmaceuticals, Roche, Sefaxersen, IgA Nephropathy, IgAN, IMAgINATION Study, Phase 3 Clinical Trial, Antisense Oligonucleotide, RNA-Targeted Therapy

CARLSBAD, Calif. — October 23, 2026 Ionis Pharmaceuticals announced new Phase 3 data from its partner Roche showing that...